Related Experiment Video
Updated: Jun 17, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[Thymic carcinoid - case report].
Lina Carvalho1, Luís Eugénio Fernandes, Filipe Ferreira
1Anatomia Patológica, Universidade de Coimbra. lcarvalho@huc.min-saude.pt
Revista Portuguesa De Pneumologia
|January 8, 2010
Summary
Primary neuroendocrine tumors, or carcinoid tumors, are rare anterior mediastinal neoplasms. Complete surgical removal is crucial for improving long-term survival rates in these aggressive tumors.
Area of Science:
- Thoracic oncology
- Neoplastic pathology
- Endocrinology
Background:
- Primary neuroendocrine tumors (carcinoid tumors) represent approximately 4% of anterior mediastinal neoplasms, specifically involving the thymus.
- These tumors exhibit a male predilection (3:1 ratio) and typically affect individuals between 40 and 60 years of age.
Observation:
- While historically classified as thymomas, they have been recognized as a distinct group of thymic neoplasia since 1972.
- These tumors can be biologically active, with a significant association (19-25%) with Multiple Endocrine Neoplasia type 1 (MEN-1), which often confers a more aggressive clinical course.
- Locally invasive disease, recurrence, and metastasis are common, correlating with a poor prognosis.
Findings:
- Tumor staging is the primary determinant of survival; early-stage encapsulated tumors have an excellent prognosis, whereas advanced-stage locally invasive tumors have a poorer prognosis.
- Complete surgical resection is the cornerstone of treatment for all thymic tumors, regardless of histologic type, and is critical for long-term survival.
Implications:
- Given their aggressive nature and association with MEN-1 and Cushing's syndrome, prophylactic thymectomy is advocated by some for affected patients.
- Early diagnosis and complete surgical removal are paramount for optimizing outcomes in patients with primary neuroendocrine tumors of the thymus.
